Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis.

Limited data are available on the vitamin D3 status and bone mineral density (BMD) of patients with psoriasis or with psoriatic arthritis. Our study intended to explore possible correlations between vitamin D status and BMD, as well as among these parameters and the features of the underlying disorder. Seventy-two patients with psoriasis/or psoriatic arthritis (female : male ratio, 40:32; mean age, 58.

[Disease burden of psoriasis associated with psoriatic arthritis in Hungary].

Introduction: Psoriasis is a frequent, chronic, systemic immune-mediated disease mainly affecting the skin and joints.

Aim: To assess health related quality of life and cost-of-illness in moderate to severe psoriasis associated with psoriatic arthritis.

Method: A cross-sectional questionnaire survey was conducted at two academic dermatology clinics in Hungary.

Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.

Background: There is a growing interest in policy making for using utility measures and identifying algorithms to convert disease-specific measures into utilities.

Objectives: To analyse the relationship between EQ-5D, Dermatology Life Quality Index (DLQI) and Psoriasis Area and Severity Index (PASI) in psoriasis. To transform DLQI scores, and key clinical, demographic and health service utilisation variables into utilities.

Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres.

Background: Despite the widespread availability of biological drugs in psoriasis, there is a shortage of disease burden studies.

Objectives: To assess the cost-of-illness and quality of life of patients with moderate to severe psoriasis in Hungary.

Methods: Consecutive patients with Psoriasis Area and Severity Index (PASI) > 10 and Dermatology Life Quality Index (DLQI) > 10, or treated with traditional systemic (TST) or biological systemic treatment (BST) were included.

The prevalence of obesity is increased in patients with late compared with early onset psoriasis.

Purpose: We compared the clinical and epidemiologic characteristics of early and late onset psoriasis with an emphasis on potential differences in the comorbidities associated with each subtype.

Methods: An observational, multicenter study was performed, and associations between the age at the time of diagnosis and binary comorbidity outcomes were evaluated using multiple logistic regression analysis adjusted for age and other relevant confounders.

Results: An increased prevalence of positive family history, psoriatic arthritis, and depression was observed in patients with early onset psoriasis.

Clinical and laboratory examinations in the subgroups of chronic urticaria.

Background: The aetiology of chronic urticaria is heterogeneous. Physical urticaria (PU) is estimated at around 35%, autoimmune urticaria (AIU) at 25% and chronic idiopathic urticaria (CIU) at 35% of all chronic urticaria cases.

Methods: Differences in clinical and laboratory parameters among AIU, PU and CIU groups were examined.